FDG-PET Response-adapted Therapy Is 18F-Fluorodeoxyglucose Positron Emission Tomography a Safe Predictor for a Change of Therapy?

被引：8
|
作者：
Hutchings, Martin [1 ]
机构：
[1] Rigshosp, Dept Haematol, DK-2100 Copenhagen, Denmark
来源：
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2014年 / 28卷 / 01期
关键词：
FDG-PET; PET/CT; Interim; Hodgkin; Lymphoma; Response adapted; UNFAVORABLE HODGKINS LYMPHOMA; CLINICAL-PRACTICE GUIDELINES; INVOLVED-FIELD RADIOTHERAPY; STEM-CELL TRANSPLANTATION; EVENT-FREE SURVIVAL; F-18-FDG PET; INTERIM-PET; CYCLES; INTERNATIONAL WORKSHOP; FINAL ANALYSIS;
D O I：
10.1016/j.hoc.2013.10.008
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT) is the most accurate tool for staging, treatment monitoring, and response evaluation in Hodgkin lymphoma (HL). Early determination of treatment sensitivity by FDG-PET is the best tool to guide individualized, response-adapted treatment. Several ongoing or recently completed trials have investigated the use of FDG-PET/CT for early response-adapted HL therapy. The results are encouraging, but the data are immature, and PET response-adapted HL therapy is discouraged outside the setting of clinical trials. PET/CT looks promising for selection of therapy in relapsed and refractory disease, but the role in this setting is still unclear.
引用
收藏
页码：87 / +
页数：18
相关论文
共 50 条
  • [1] 18F-Fluorodeoxyglucose positron emission tomography (FDG-PET) staging of esophageal cancer
    Jager, P. L.
    EJC SUPPLEMENTS, 2005, 3 (02): : 37 - 37
  • [2] MANAGEMENT OF PRIMARY TUMOURS OF THE THYMUS AND USEFULNESS OF 18F-FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY (FDG-PET)
    Moraitis, Sotirios D.
    Gkiozos, Ioannis
    Kanakakis, Konstantinos
    Moraitis, Dimitrios S.
    Syrigos, Konstantinos N.
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S944 - S945
  • [3] Hypoxia and glucose metabolism in oesophageal tumours: correlation with 18F-fluorodeoxyglucose positron emission tomography (FDG-PET)
    Raouf, A.
    Power, C.
    Malik, V
    Russell, S.
    Griffin, M.
    Reynolds, J.
    ANNALS OF ONCOLOGY, 2007, 18 : VII50 - VII50
  • [4] The use of 18F-Fluorodeoxyglucose Positron Emission Tomography (18F-FDG PET) as a predictor of metastasis and response to inhibition of glucose metabolism.
    Lee, Misu
    Jeon, JeongYong
    Kim, JiSook
    Yun, Mijin
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [5] Multifocal Nodular Lymphoid Hyperplasia of the Lung Differently Identified by 18F-Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)
    Nakamura, H.
    Miwa, K.
    Haruki, T.
    Adachi, Y.
    Fujioka, S.
    Taniguchi, Y.
    THORACIC AND CARDIOVASCULAR SURGEON, 2009, 57 (07): : 439 - 440
  • [6] 18F-Fluorodeoxyglucose positron emission tomography (FDG-PET) as a prognostic and predictive biomarker in metastatic colorectal cancer (mCRC)
    Philip, P. A.
    Gupta, S.
    Heilbrun, L.
    Smith, D.
    El-Rayes, B.
    Shields, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [7] Positron emission tomography with F-18-fluorodeoxyglucose (FDG-PET) in the diagnosis of liver tumors
    Fujimoto, Masazumi
    Toda, Yasunobu
    Inai, Maki
    Ishihara, Maki
    Asagoe, Kensuke
    Kawai, Toshihide
    Mizuta, Kazuhiko
    Kudo, Takashi
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 : A174 - A174
  • [8] 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG-PET/CT) Imaging in the Staging and Prognosis of Inflammatory Breast Cancer
    Alberini, Jean-Louis
    Lerebours, Florence
    Wartski, Myriam
    Fourme, Emmanuelle
    Le Stanc, Elise
    Gontier, E.
    Madar, O.
    Cherel, P.
    Pecking, A. P.
    CANCER, 2009, 115 (21) : 5038 - 5047
  • [9] The value of vesicant 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET) in gastric malignancies
    Tian, JH
    Chen, L
    Wei, B
    Shao, MZ
    Ding, Y
    Yin, DY
    Yao, SL
    NUCLEAR MEDICINE COMMUNICATIONS, 2004, 25 (08) : 825 - 831
  • [10] Task Group 174 Report: Utilization of [18F]Fluorodeoxyglucose Positron Emission Tomography ([18F]FDG-PET) in Radiation Therapy
    Das, Shiva K.
    McGurk, Ross
    Miften, Moyed
    Mutic, Sasa
    Bowsher, James
    Bayouth, John
    Erdi, Yusuf
    Mawlawi, Osama
    Boellaard, Ronald
    Bowen, Stephen R.
    Xing, Lei
    Bradley, Jeffrey
    Schoder, Heiko
    Yin, Fang-Fang
    Sullivan, Daniel C.
    Kinahan, Paul
    MEDICAL PHYSICS, 2019, 46 (10) : E706 - E725
12345